JT

Jim Tananbaum

North America, California, United States, San Francisco

Description

Dr. Tananbaum is the founding CEO of Foresite Capital Management. He has led investments in 21 successful healthcare companies, including...

Investor Profile

Jim Tananbaum has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series E (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Oncology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jim Tananbaum frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
RO
North America, California, United States, Oakland
Co-Investments: 1
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 1
DC
North America, Illinois, United States, Chicago
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
The Column Group
North America, California, United States, San Francisco
Co-Investments: 1
CV
North America, Texas, United States, Dallas
Co-Investments: 1

What are some of recent deals done by Jim Tananbaum?

Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series EFeb 20, 2019
Amount Raised: $150,000,000